Hope Bancorp, Inc. logo HOPE - Hope Bancorp, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 1
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.50 DETAILS
HIGH: $14.50
LOW: $14.50
MEDIAN: $14.50
CONSENSUS: $14.50
UPSIDE: 5.76%

Stock News

OLD REPUBLIC ANNOUNCES NATIONAL PARTNERSHIP WITH HOPE FOR THE WARRIORS®

OLD REPUBLIC ANNOUNCES NATIONAL PARTNERSHIP WITH HOPE FOR THE WARRIORS®

CHICAGO, July 20, 2026 /PRNewswire/ -- Old Republic International Corporation (NYSE: ORI) – today announced a national partnership with Hope For The Warriors® (HOPE), a nonprofit organization dedicated to supporting veterans, service members, military families, and caregivers. The partnership reflects a shared commitment to strengthening communities by supporting those who have served our country and the families who serve alongside them.

Jul 20, 2026 09:00 AM prnewswire.com
Hope Bancorp to Report Financial Results for the Second Quarter and Six Months Ended June 30, 2026, on Monday, July 27, 2026

Hope Bancorp to Report Financial Results for the Second Quarter and Six Months Ended June 30, 2026, on Monday, July 27, 2026

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (“the Company”) (NASDAQ: HOPE) today announced that the Company will report financial results for its second quarter and six months ended June 30, 2026, before the markets open on Monday, July 27, 2026.A conference call to discuss financial results for the second quarter ended June 30, 2026, will be held on Monday, July 27, 2026, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A presentation deck to accompany the earnings call will be availab.

Jul 13, 2026 12:30 PM businesswire.com
Hope Bancorp: Getting Increasingly Interesting Despite Higher Provisions

Hope Bancorp: Getting Increasingly Interesting Despite Higher Provisions

Hope Bancorp delivered robust Q1 results, driven by a significant net interest margin expansion and disciplined cost control. HOPE's commercial real estate portfolio remains resilient, with an average LTV of 47% and minimal charge-offs, mitigating CRE risk concerns. The pending Manubank acquisition is expected to boost loans and deposits by 17% and drive EPS accretion of over 20%, with a 23% IRR.

Jul 10, 2026 06:30 AM seekingalpha.com
VERSABANK DONATES $60,000 TO THE SALVATION ARMY'S HARVEST HOPE CAMPAIGN

VERSABANK DONATES $60,000 TO THE SALVATION ARMY'S HARVEST HOPE CAMPAIGN

LONDON, ON, June 29, 2026 /PRNewswire/ - VersaBank (TSX: VBNK) (Nasdaq: VBNK) today announced it made a $60,000 donation to The Salvation Army's Harvest Hope Campaign and presented a cheque to The Salvation Army executives in front of approximately 700 people at VersaBank's Summer Celebration event in London, Ontario on Saturday, June 27, 2026. "This economy is proving difficult for many people and I've always felt that it's important to help people out in a time of need," said David Taylor, Founder and President, VersaBank.

Jun 29, 2026 09:00 AM prnewswire.com
Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the Company's lead cell therapy candidate for Duchenne Muscular Dystrophy (DMD). The data will be presented at the Parent Project Muscular Dystrophy (PPMD) 2026 Annual Conference, taking place June 25-27, 2026, in Orlando, Florida, alongside previously reported results from the Company's HOPE-3 Phase 3 trial.

Jun 26, 2026 05:05 AM globenewswire.com
AGNICO EAGLE APPROVES HOPE BAY INVESTMENT DECISION; STRONG ECONOMIC RETURNS WITH EXPECTED ANNUAL GOLD PRODUCTION OF OVER 400,000 OUNCES

AGNICO EAGLE APPROVES HOPE BAY INVESTMENT DECISION; STRONG ECONOMIC RETURNS WITH EXPECTED ANNUAL GOLD PRODUCTION OF OVER 400,000 OUNCES

Stock Symbol: AEM (NYSE and TSX) (All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, May 19, 2026 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) ("Agnico Eagle" or the "Company") is pleased to report a positive investment decision for its Hope Bay project, located in Nunavut, Canada. Following significant exploration success in recent years, the Company has completed a preliminary economic assessment (the "2026 Study") which contemplates an underground mining operation supported by a 6,000 tonnes per day ("tpd") processing facility with estimated annual gold production of between 400,000 and 435,000 ounces.

May 19, 2026 02:00 AM prnewswire.com
Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per common share. The dividend is payable on or about May 22, 2026, to all stockholders of record as of the close of business on May 8, 2026. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ: HOPE) is the holding company for Bank of Hope, with $18.66 billion in total assets as of March 31, 2026. Following the addition of Terri.

Apr 28, 2026 03:30 AM businesswire.com
Hope Bancorp Reports Financial Results for the First Quarter Ended March 31, 2026

Hope Bancorp Reports Financial Results for the First Quarter Ended March 31, 2026

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company” or “Hope”) (NASDAQ: HOPE), the holding company of Bank of Hope (the “Bank”), today reported unaudited financial results for its first quarter ended March 31, 2026. For the three months ended March 31, 2026, the Company recorded net income of $29.5 million, or $0.23 per diluted common share, up 40% from net income of $21.1 million, or $0.17 per diluted common share, for the three months ended March 31, 2025, and down 14% from net in.

Apr 28, 2026 03:30 AM businesswire.com
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

GOTHENBURG, SE / ACCESS Newswire / April 22, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, the results from the HOPE-at-Heart clinical trial (NCT06485596) were presented at the ISHLT Annual Meeting in Toronto. This prospective, multicenter trial, is the first to evaluate direct procurement of donor hearts after circulatory death (DCD) followed by preservation using HOPE with the XVIVO Heart Assist Transport.

Apr 22, 2026 12:10 PM accessnewswire.com
Hope Bancorp to Report Financial Results for the First Quarter Ended March 31, 2026, on Tuesday, April 28, 2026

Hope Bancorp to Report Financial Results for the First Quarter Ended March 31, 2026, on Tuesday, April 28, 2026

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (“the Company”) (NASDAQ: HOPE) today announced that the Company will report financial results for its first quarter ended March 31, 2026, before the markets open on Tuesday, April 28, 2026. A conference call to discuss financial results for the first quarter ended March 31, 2026, will be held on Tuesday, April 28, 2026, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A presentation deck to accompany the earnings call will be available on Hop.

Apr 14, 2026 03:30 AM businesswire.com

Price Targets